Adomiparin sodium

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameAdomiparin sodium
Drug Alias Nameadomiparinum natricum阿米肝素钠阿多肝素钠adomiparine sodiqueM-118
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsCoronary Artery Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMomenta
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMomenta Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCoronary Artery Disease

Other Information

ATC CodeN/A
Related LinksKEGG